69 Best Biotech Startups in Lausanne to Watch in 2024

Gene and cell therapy manufacturing.

Total Raised: $50.42M

Last Funding: $50.42M (Series A)

Manufacturer of drugs to combat the effects of ageing.

Total Raised: $10.90M

Last Funding: $10.90M (Series A)

Developer of treatments for neurodegenerative diseases.

Total Raised: $100.00M

Last Funding: $100.00M (Series C)

Platform for observing live cells in 3D without damaging them.

Total Raised: $22.20M

Last Funding: $20.00M (Unknown)

Platform providing digital assessments and therapies for patient treatment and rehabilitation.

Total Raised: $125.00M

Last Funding: $125.00M (Unknown)

Small molecule mitophagy inducers developer.

Total Raised: $20.66M

Last Funding: $20.66M (Series A)

RNA sequencing and transcriptomics analysis platform.

Total Raised: $3.29M

Last Funding: $3.18M (Seed)

Tumor immunotherapy drug developer.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

Total Raised: $2.33M

Last Funding: $2.16M (Seed)

Rheon focuses on the development of first-in-class glaucoma drainage devices.

Total Raised: $6.29M

Last Funding: $6.29M (Unknown)

Accurate monitoring and treatment platform for sleep bruxism and sleep apnea.

Total Raised: $3.00M

Last Funding: $3.00M (Seed)

Device improving comfort during gynecological procedures.

Total Raised: $5.00M

Last Funding: $5.00M (Unknown)

Renewable system for onsite production of solar fuel and power, offering a cleaner, greener, and cost-effective solution.

Total Raised: $2.00M

Last Funding: $2.00M (Seed)

Self-testing kit provider for quick, at-home medical results.

Total Raised: $1.73M

Last Funding: $1.73M (Seed)

Molecular analysis technology developer.

Total Raised: $1.90M

Last Funding: $1.90M (Pre Seed)

Biotech firm focused on creating personalized molecular therapies for cancer patients.

Total Raised: $1.10M

Last Funding: $1.10M (Seed)

Medical device designed to restore erectile function in patients unresponsive to oral medications.

Total Raised: $0.83M

Last Funding: $0.83M (Pre Seed)

Protein engineering platform using cell-free synthetic biology and nanofluidics.

Total Raised: $0.12M

Last Funding: $0.00M (Unknown)

Device that automatically inspects and sorts miniature biological entities.

Total Raised: $0.17M

Last Funding: $0.17M (Pre Seed)

Anti-cancer drug evaluator.

Total Raised: $0.17M

Last Funding: $0.17M (Pre Seed)

High-selective nerve stimulators developer for the treatment of neuropathic pain.